Crispr Therapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by TD Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $14M | 226k | 62.60 |
| 2023-09-30 | $11M | 241k | 45.39 |
| 2023-06-30 | $12M | 213k | 56.14 |
| 2023-03-31 | $9.5M | 210k | 45.23 |
| 2022-12-31 | $7.4M | 182k | 40.65 |
| 2022-09-30 | $7.4M | 115k | 64.49 |
| 2022-06-30 | $6.3M | 104k | 60.77 |
| 2022-03-31 | $2.0M | 32k | 62.76 |
| 2021-12-31 | $2.6M | 34k | 75.77 |
| 2021-09-30 | $3.4M | 30k | 111.92 |
| 2021-06-30 | $3.7M | 30k | 121.03 |
| 2021-03-31 | $3.8M | 31k | 121.86 |
| 2020-12-31 | $4.9M | 32k | 153.12 |